Literature DB >> 23904440

CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.

Maria Lampinen1, Amanda Waddell, Richard Ahrens, Marie Carlson, Simon P Hogan.   

Abstract

This study tested the hypothesis that eotaxins (CCL11, CCL24, and CCL26) and IL-5 contribute to eosinophil recruitment to the intestine in UC and that intestinal macrophages are important producers of CCL11 in this disease. Peripheral blood and rectal biopsy samples were obtained from patients with active (n=18) and quiescent UC (n=9), and control patients (n=7). Eosinophil and macrophage levels and activation were analyzed by flow cytometry. Rectal mRNA levels of CCL11, CCL24, CCL26, and IL-5 were determined by qRT-PCR. The cellular source of CCL11 was visualized by immunofluorescence analyses. Eosinophil numbers were elevated in the blood and rectum of active and quiescent UC patients compared with controls. Levels of activated eosinophils (CD66b(high)) correlated with disease severity. Rectal CCL11, CCL24, and CCL26 mRNA levels were increased in active UC, whereas only CCL11 was elevated in quiescent UC. Levels of CCL11, but not CCL24 and CCL26, positively correlated with eosinophil numbers. Numbers of CD14(+)CD33(+) cells correlated with CCL11 and eosinophil levels. Immunofluorescence analyses revealed the presence of CD14(+)CCL11(+) mononuclear cells in colonic biopsies in UC. These results support the hypothesis that CCL11 contributes to eosinophil recruitment in UC and that intestinal myeloid cells are a source of CCL11. Interestingly, rectal levels of CCL24, CCL26, and IL-5 only increase during active UC, coinciding with further elevation of eosinophil numbers and with the activation of rectal eosinophils. In conclusion, there is a link among CD14(+)CD33(+) myeloid cells, CCL11, and eosinophils in adult UC.

Entities:  

Keywords:  chemokine; eotaxins; inflammatory bowel disease

Mesh:

Substances:

Year:  2013        PMID: 23904440      PMCID: PMC3800069          DOI: 10.1189/jlb.1212640

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  64 in total

1.  Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.

Authors:  P D Smith; L E Smythies; M Mosteller-Barnum; D A Sibley; M W Russell; M Merger; M T Sellers; J M Orenstein; T Shimada; M F Graham; H Kubagawa
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 2.  The eosinophil.

Authors:  Marc E Rothenberg; Simon P Hogan
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 3.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

Review 4.  Eosinophils: biological properties and role in health and disease.

Authors:  Simon P Hogan; Helene F Rosenberg; Redwan Moqbel; Simon Phipps; Paul S Foster; Paige Lacy; A Barry Kay; Marc E Rothenberg
Journal:  Clin Exp Allergy       Date:  2008-04-01       Impact factor: 5.018

5.  Identification of the cytokine RANTES released from platelets as an eosinophil chemotactic factor.

Authors:  Y Kameyoshi; J M Schröder; E Christophers; S Yamamoto
Journal:  Int Arch Allergy Immunol       Date:  1994       Impact factor: 2.749

Review 6.  The effects of glucocorticoids on human eosinophils.

Authors:  R P Schleimer; B S Bochner
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

7.  C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).

Authors:  S Ying; D S Robinson; Q Meng; L T Barata; A R McEuen; M G Buckley; A F Walls; P W Askenase; A B Kay
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

8.  Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration.

Authors:  K Amin; J Rinne; T Haahtela; M Simola; C G Peterson; G M Roomans; H Malmberg; P Venge; L Sevéus
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

9.  Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis.

Authors:  Jacob Tveiten Bjerrum; Morten Hansen; Jørgen Olsen; Ole Haagen Nielsen
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

10.  Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids.

Authors:  Miles Edwin Banwell; Neil Samuel Tolley; Timothy John Williams; Tracey Jane Mitchell
Journal:  Cytokine       Date:  2002-03-21       Impact factor: 3.861

View more
  25 in total

1.  The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.

Authors:  Tomer Adar; Shimon Shteingart; Ami Ben-Ya'acov; Ariella Bar-Gill Shitrit; Dan M Livovsky; Shimrit Shmorak; Mahmud Mahamid; Bernardo Melamud; Fiona Vernea; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-02-13       Impact factor: 3.199

2.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

3.  IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.

Authors:  Carlo De Salvo; Xiao-Ming Wang; Luca Pastorelli; Benedetta Mattioli; Sara Omenetti; Kristine A Buela; Saleem Chowdhry; Rekha R Garg; Wendy A Goodman; Alex Rodriguez-Palacios; Dirk E Smith; Derek W Abbott; Fabio Cominelli; Giorgos Bamias; Wei Xin; James J Lee; Maurizio Vecchi; Theresa T Pizarro
Journal:  Am J Pathol       Date:  2016-02-22       Impact factor: 4.307

Review 4.  The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.

Authors:  K Jovanovic; M Siebeck; R Gropp
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 5.  Regional specialization within the intestinal immune system.

Authors:  Allan M Mowat; William W Agace
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

6.  A key requirement for CD300f in innate immune responses of eosinophils in colitis.

Authors:  I Moshkovits; H Reichman; D Karo-Atar; P Rozenberg; E Zigmond; Y Haberman; N Ben Baruch-Morgenstern; M Lampinen; M Carlson; M Itan; L A Denson; C Varol; A Munitz
Journal:  Mucosal Immunol       Date:  2016-04-27       Impact factor: 7.313

Review 7.  Colonic macrophage polarization in homeostasis, inflammation, and cancer.

Authors:  Raymond A Isidro; Caroline B Appleyard
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-26       Impact factor: 4.052

Review 8.  Modulators affecting the immune dialogue between human immune and colon cancer cells.

Authors:  Meir Djaldetti; Hanna Bessler
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

Review 9.  Novel targeted therapies for eosinophil-associated diseases and allergy.

Authors:  Susanne Radonjic-Hoesli; Peter Valent; Amy D Klion; Michael E Wechsler; Hans-Uwe Simon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-17       Impact factor: 13.820

Review 10.  Diversity and functions of intestinal mononuclear phagocytes.

Authors:  T Joeris; K Müller-Luda; W W Agace; A McI Mowat
Journal:  Mucosal Immunol       Date:  2017-04-05       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.